Analysis Metabolite Name Measured Value Units AGE DIET SAMPLE_TYPE
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.459.77761728Peak area normalized24 week Control plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4599.14147004Peak area normalized16 week HF STZ plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.45125.2372598Peak area normalized16 week Control plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.45219.0766303Peak area normalized16 week HF STZ plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.45673.1493586Peak area normalized16 week HF plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.45827.7553823Peak area normalized16 week HF plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.45958.8862948Peak area normalized24 week HF STZ DR plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.45976.5388098Peak area normalized16 week Control plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.451074.224236Peak area normalized24 week HF STZ plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.451275.724394Peak area normalized24 week Control plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.451352.698163Peak area normalized24 week HF STZ DR plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.451385.102849Peak area normalized16 week Control plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.451485.980061Peak area normalized16 week Control plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.451512.920249Peak area normalized24 week HF STZ DR plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.451526.899091Peak area normalized24 week Control plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.451532.374442Peak area normalized24 week HF STZ DR plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.451538.719009Peak area normalized16 week Control plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.451583.501803Peak area normalized24 week Control plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.451594.323071Peak area normalized16 week Control plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.451783.486909Peak area normalized24 week HF DR plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.451800.561779Peak area normalized24 week Control plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.451805.647717Peak area normalized24 week Control plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.451892.158723Peak area normalized16 week HF STZ plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.451930.479408Peak area normalized24 week HF plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.452186.739797Peak area normalized24 week HF DR plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.452210.111364Peak area normalized24 week HF STZ Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.452346.165679Peak area normalized24 week HF STZ plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.452479.33966Peak area normalized24 week HF STZ plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.452544.903765Peak area normalized24 week Control plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.452557.656652Peak area normalized24 week Control plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.452723.797337Peak area normalized24 week HF plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.452755.882375Peak area normalized24 week HF STZ Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.452765.679096Peak area normalized16 week HF STZ plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.452781.560764Peak area normalized24 week HF DR plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.452799.846891Peak area normalized24 week HF STZ plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.452827.995521Peak area normalized24 week HF DR plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.452867.10291Peak area normalized16 week HF STZ plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.452872.592844Peak area normalized16 week HF plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.452917.981946Peak area normalized24 week HF DR plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.453064.693304Peak area normalized24 week HF STZ DR Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.453180.150256Peak area normalized24 week HF STZ Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.453189.451851Peak area normalized16 week Control plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.453226.298199Peak area normalized24 week HF DR plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.453242.46494Peak area normalized24 week HF STZ DR plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.453404.467019Peak area normalized24 week HF STZ Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.453452.781233Peak area normalized24 week Control plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.453541.05805Peak area normalized24 week HF DR plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.453645.873764Peak area normalized16 week Control plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.453680.231901Peak area normalized24 week HF DR plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.453839.118493Peak area normalized24 week HF DR plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.453885.18153Peak area normalized24 week HF STZ plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.453909.369187Peak area normalized24 week HF DR plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.453964.890411Peak area normalized16 week HF STZ Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.453975.595512Peak area normalized24 week HF Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.454036.904703Peak area normalized24 week HF STZ DR plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.454062.014421Peak area normalized16 week HF STZ plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.454091.096218Peak area normalized16 week HF STZ plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.454315.705727Peak area normalized24 week HF STZ DR plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.454418.585766Peak area normalized16 week HF STZ Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.454422.082329Peak area normalized24 week control Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.454465.471358Peak area normalized16 week HF plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.454548.986085Peak area normalized16 week HF Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.454577.536416Peak area normalized16 week HF STZ plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.454580.309722Peak area normalized24 week HF STZ plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.454729.132216Peak area normalized16 week HF STZ plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.454835.559458Peak area normalized16 week HF Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.454871.145749Peak area normalized24 week HF STZ DR plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.454925.916069Peak area normalized16 week HF plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.455051.475949Peak area normalized16 week Control plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.455114.8293Peak area normalized24 week Control plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.455179.183832Peak area normalized16 week Control plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.455278.506234Peak area normalized24 week control Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.455442.736668Peak area normalized24 week HF STZ DR plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.455506.719761Peak area normalized24 week HF STZ Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.455507.634381Peak area normalized24 week control Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.455527.068593Peak area normalized24 week HF STZ DR Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.455568.28533Peak area normalized24 week HF DR Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.455777.701571Peak area normalized24 week HF DR Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.455778.125345Peak area normalized24 week HF STZ DR plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.455872.655962Peak area normalized24 week HF DR Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.455877.592055Peak area normalized24 week control Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.455939.069389Peak area normalized16 week HF Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.456014.408076Peak area normalized16 week HF Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.456015.389423Peak area normalized16 week HF plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.456031.491936Peak area normalized16 week control Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.456242.448938Peak area normalized16 week HF plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.456320.661424Peak area normalized24 week HF STZ plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.456401.412495Peak area normalized24 week HF plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.456505.697815Peak area normalized24 week HF plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.456527.332085Peak area normalized24 week HF STZ Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.456536.731074Peak area normalized24 week HF DR Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.456620.953264Peak area normalized16 week control Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.456717.630904Peak area normalized24 week control Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.456779.700769Peak area normalized24 week HF STZ plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.456796.533265Peak area normalized24 week HF STZ DR Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.456872.897693Peak area normalized16 week control Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.456896.149187Peak area normalized16 week HF plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.456931.302771Peak area normalized24 week HF STZ DR Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.456951.734031Peak area normalized16 week control Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.457065.595148Peak area normalized24 week HF STZ DR Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.457285.163812Peak area normalized16 week control Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.457311.653295Peak area normalized24 week control Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.457399.909559Peak area normalized16 week HF plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.457597.68003Peak area normalized24 week HF STZ Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.457906.034351Peak area normalized24 week HF DR Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.457922.910674Peak area normalized24 week HF plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.458004.570063Peak area normalized16 week HF STZ Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.458198.416416Peak area normalized24 week HF Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.458338.435178Peak area normalized16 week HF plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.458422.059119Peak area normalized24 week HF DR Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.458545.193706Peak area normalized16 week control Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.458617.594115Peak area normalized24 week HF STZ plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.458638.846613Peak area normalized24 week control Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.458800.61443Peak area normalized24 week HF Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.458813.199539Peak area normalized24 week HF STZ DR Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.459054.575804Peak area normalized24 week HF STZ DR Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.459281.330071Peak area normalized24 week HF DR Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.459657.651159Peak area normalized24 week HF Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.459669.563676Peak area normalized24 week HF DR Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.459981.10899Peak area normalized16 week control Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4510017.64934Peak area normalized24 week HF plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4510078.52779Peak area normalized16 week control Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4510202.22992Peak area normalized24 week control Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4510629.89246Peak area normalized24 week HF Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4510711.57827Peak area normalized24 week HF STZ Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4510894.6633Peak area normalized16 week control Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4511138.30751Peak area normalized24 week HF Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4511190.33206Peak area normalized24 week HF Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4511641.08959Peak area normalized24 week HF STZ DR Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4511828.35962Peak area normalized24 week HF plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4512086.09624Peak area normalized24 week HF STZ DR Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4512171.53457Peak area normalized24 week HF Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4512217.73709Peak area normalized16 week HF Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4512961.37447Peak area normalized24 week HF STZ Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4513053.21183Peak area normalized16 week HF STZ Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4513095.9416Peak area normalized24 week control Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4513422.41715Peak area normalized16 week HF Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4513615.65923Peak area normalized24 week HF DR Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4513762.50623Peak area normalized16 week HF Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4514042.54592Peak area normalized24 week HF plasma
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4514488.73681Peak area normalized16 week HF Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4515206.03726Peak area normalized24 week HF STZ Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4515562.73569Peak area normalized16 week HF Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4516437.20226Peak area normalized16 week control Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4516551.27275Peak area normalized24 week HF STZ DR Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4516894.73077Peak area normalized16 week HF STZ Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4517557.14896Peak area normalized16 week HF STZ Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4518034.33369Peak area normalized24 week HF Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4518087.28318Peak area normalized16 week HF Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4518555.50131Peak area normalized16 week HF STZ Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4519221.94616Peak area normalized24 week HF Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4519332.12704Peak area normalized16 week HF STZ Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4520849.00819Peak area normalized16 week HF STZ Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4524134.99381Peak area normalized16 week Control Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4525493.16849Peak area normalized16 week Control Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4527195.3885Peak area normalized24 week HF DR Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4529101.8545Peak area normalized24 week Control Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4530451.36248Peak area normalized16 week HF Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4532560.18352Peak area normalized24 week HF STZ DR Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4535775.62455Peak area normalized24 week HF STZ DR Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4537671.53315Peak area normalized16 week HF STZ Sciatic nerve
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4541088.46477Peak area normalized16 week HF Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4541495.42337Peak area normalized16 week Control Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4542414.32487Peak area normalized24 week HF STZ Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4543360.09772Peak area normalized24 week Control Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4544452.79128Peak area normalized24 week HF STZ Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4546377.94651Peak area normalized24 week HF Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4547251.01284Peak area normalized24 week HF Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4548691.91823Peak area normalized16 week HF Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4550223.51846Peak area normalized24 week HF DR Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4550442.23165Peak area normalized16 week HF STZ Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4550785.44418Peak area normalized16 week HF Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4551062.33619Peak area normalized24 week Control Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4551683.43119Peak area normalized16 week HF Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4553568.39954Peak area normalized24 week Control Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4556654.65739Peak area normalized24 week HF STZ Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4557329.12142Peak area normalized24 week HF DR Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4559620.62224Peak area normalized24 week Control Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4561482.16666Peak area normalized24 week HF Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4561939.52142Peak area normalized16 week Control Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4562198.07574Peak area normalized24 week Control Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4564661.86586Peak area normalized16 week HF STZ Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4567787.11454Peak area normalized16 week HF Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4568359.15172Peak area normalized24 week Control Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4568962.16377Peak area normalized16 week HF STZ Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4570294.71516Peak area normalized24 week Control Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4570379.04499Peak area normalized24 week HF DR Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4572702.45174Peak area normalized24 week HF STZ Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4572821.93751Peak area normalized16 week HF STZ Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4573033.36437Peak area normalized24 week HF DR Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4573922.67593Peak area normalized24 week HF Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4576112.95577Peak area normalized24 week HF STZ DR Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4577483.49543Peak area normalized16 week Control Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4579220.18301Peak area normalized24 week HF Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4580224.69366Peak area normalized24 week Control Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4580641.60468Peak area normalized16 week Control Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4582282.85143Peak area normalized16 week Control Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4583141.06286Peak area normalized24 week HF STZ Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4583461.41306Peak area normalized16 week HF Dorsal root ganglia
C18 NEGATIVE ION MODEN-(octadecanoyl)-sphing-4-enine; [M-H]-@7.4586796.97261Peak area normalized24 week HF STZ DR Dorsal root ganglia

Return to search page
  logo